--:--:--

IPCA Laboratories Limited

Web: ipca.com NSE: IPCALAB BSE: 524494 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

1921 106(6%)

Near 52W High of 2038

Volume

2L as on 16, Oct

Open

1,468

High

1,747

Low

1,686

Close

1,814

VWAP

1,851

52 Week High

2,038

52 Week Low

1,252

Viand Research Rating
Quality Score

80/100

Growth Score

68/100

Valuation Score

50/100

Momentum Score

50/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy
Analyst Price Target
-
Market Cap (cr)

48,737

No. of Shares

25.4

P/E

59.03

P/B

5.69

Face Value

1

Div. Yield

-

Book Value (TTM)

-

CASH

-

DEBT

-

EPS (TTM)

-

ROE

9.65

ROCE

-

Profit Growth

-

Listing Date

08-Feb-95

Rank/Sector Rank

#203/#19

Promoter Holding

44.72%

FII Holding

10.72%

DII Holding

37.04%

Price Chart
Price Performance
1 Week4%
1 Month6%
3 Months3%
6 Months25%
1 Year44%
YTD31%
Moving Average
5 Day SMA1,895
10 Day SMA1,917
20 Day SMA1,942
30 Day SMA1,948
50 Day SMA1,915
61 Day SMA1,887
80 Day SMA1,859
200 Day SMA1,653
PIVOT LEVEL
StandardCamarillaFibonacciWoodie's
Resistance 31,9751,9251,9521,970
Resistance 21,9521,9211,9361,950
Resistance 11,9331,9171,9261,928
Pivot Point1,9101,9131,9101,908
Support 11,8911,9091,8941,886
Support 21,8681,9051,8841,866
Support 31,8491,9021,8681,844
Competitors/Peers
#SymbolMCAPLTP1W1M6M1YP/EInd PEDebt/EqNP Qtr Rs.Cr.
1SUNPHARMA4,18,69817450%5%4%4%3755.50.0711509
2DIVISLAB2,43,96691902%0%45%38%6955.502568
3TORNTPHARM1,73,20845542%5%10%28%7255.51.792138
4ZYDUSLIFE1,11,45111170%1%20%12%2055.50.313560
5APOLLOHOSP1,09,27676002%9%4%1%5855.50.92003
6LAURUSLABS1,08,73820121%8%83%124%055.50.48890
7CIPLA1,06,15413142%2%8%19%2255.50.023862
8DRREDDY1,03,87312443%8%1%4%2055.50.24158
9MANKIND94,40122864%1%8%7%4955.50.391938
10AUROPHARMA90,84115792%1%20%52%055.50.192415
Load More
Shareholding Pattern (%)
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
Promoters(0.01) 44.72%(0.01) 44.72%(0.01) 44.72%(0.01) 44.72%(0.01) 44.72%(0.01) 44.72%(-1.61) 44.72%(0.01) 46.30%(0.01) 46.30%(0.01) 46.30%(0.01) 46.29%(0.01) 46.29%(0.01) 46.29%(0.01) 46.29%(0.01) 46.29%(0.01) 46.29%(0.01) 46.29%(0.01) 46.29%(0.01) 46.29%(0.01) 46.29%
FIIs(0.11) 10.72%(0.01) 10.63%(0.21) 10.62%(-0.31) 10.42%(-0.11) 10.67%(-0.31) 10.75%(0.21) 11.06%(0.01) 10.83%(0.31) 10.85%(0.21) 10.51%(0.41) 10.27%(-0.21) 9.86%(-0.51) 10.05%(0.11) 10.58%(-0.11) 10.46%(0.01) 10.57%(-0.41) 10.61%(-1.31) 11.02%(-6.11) 12.34%(0.01) 18.46%
DIIs(-0.11) 37.04%(0.11) 37.13%(0.51) 36.99%(0.61) 36.45%(0.21) 35.88%(0.41) 35.73%(1.51) 35.36%(0.41) 33.90%(-0.61) 33.46%(-0.11) 34.05%(-0.51) 34.19%(-0.11) 34.72%(1.11) 34.86%(0.01) 33.74%(0.31) 33.71%(0.01) 33.46%(0.81) 33.49%(2.71) 32.70%(4.81) 30.02%(0.01) 25.24%
Government0.32%0.32%0.32%0.32%0.32%0.32%0.32%0.32%0.32%0.32%0.32%0.32%0.32%0.32%0.32%0.32%0.24%0.24%0.24%0.22%
Public7.19%7.21%7.33%8.09%8.41%8.45%8.53%8.64%9.07%8.82%8.93%8.80%8.46%9.06%9.22%9.34%9.37%9.75%11.11%9.80%
No. of Shareholders82,06082,18477,67382,87085,58288,30690,18982,97584,75381,16582,80995,93099,889110,296108,177111,043110,818115,335106,77995,239
Quarterly Results
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021
Sales278823882392255623092247224523552093203320532034158515121546160115861289143015441566
Sales Growth % (YoY)20.8%6.3%6.6%8.6%10.3%10.5%9.4%15.8%32%34.5%32.8%27%0%17.3%8.1%3.7%1.3%15.6%1.5%13.5%2%
Sales Growth % (QoQ)16.8%-0.2%-6.4%10.7%2.8%0.1%-4.7%12.5%3%-1%0.9%28.3%4.8%-2.2%-3.4%0.9%23%-9.9%-7.4%-1.4%-
Expenses211919051859201218921818178219131700171117221673127813311330134113171070112311841152
Operating Profit670484533545416429463441393322331361308181216260269219308360414
OPM %242022211819211919161618191214161717222326
Other Income254838-3033-179202621-11891-1453631362215121821
Interest122018201922172324293344311811973112
Depreciation11110710810310010098100999810090697067646261595756
Profit before tax57240444639233112836834529077289225252129169223223170260320377
Tax %262418282949252931962339343732353317222119
Net Profit 42430736428123364276246199122113616478110146145132198252307
Net Profit Growth % (QoQ)38.1%-15.7%29.5%20.6%264.1%-76.8%12.2%23.6%19800%-99.5%62.5%-17.1%110.3%-29.1%-24.7%0.7%9.8%-33.3%-21.4%-17.9%-
Net Profit Growth % (YoY)82%379.7%31.9%14.2%17.1%6300%24.9%80.9%21.3%-98.7%100.9%-6.8%13.1%-40.9%-44.4%-42.1%-52.8%----
TTM Net Profit137611859428548197857226675575225994884984795336217278897575590
EPS in Rs15.8411.7912.8611.149.192.679.789.057.582.357.095.726.423.024.255.675.645.137.749.8612.09
Profit and Loss
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013
Sales95998897766262045797539546193746325831562867314432822813
Sales Growth %7.9%16.1%23.5%7%7.4%16.8%23.3%15%3.2%10.1%-8.8%-4.2%16.7%19.3%
Expenses76097166633852724472384337153051280327052573260425392248
Operating Profit19901731132493213251552904695455451294541743565
OPM %2119171523292019141410172320
Other Income80-1141712354596556411121322113
Interest79881414811122022282735323036
Depreciation41839835726223220921018217817316318010387
Profit before tax1573113184374511361389739546291262117361631454
Tax %2430373420171819182618282429
Net Profit 1184785523479890114160444223919593254479324
Net Profit Growth %50.8%50.1%9.2%-46.2%-22%88.9%36.7%84.9%22.6%109.7%-63.4%-47%47.8%-
EPS in Rs44.9829.0821.5718.5834.8544.9423.9917.69.497.713.6910.0718.9612.82
Dividend Payout %014192211910956051316
Cash Flows
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013
Cash from Operating Activity114213219458068561090570501341282709468522389
Cash from Investing Activity-247-870-1215-725-851-521-509-165-135-149-218-689-369-260
Cash from Financing Activity-754-283-553507427-306-137-183-130-159-462251-136-83
Net Cash Flow142169-823588432264-7615375-2629291846
Balance Sheet
Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013
Equity Capital25252525252525252525252525252525
Reserves8038740269236675630758175467467636023097266324302234218319341529
Borrowings80912791363120214381481807265501465628716867935603617
Other Liabilities347735573432352133261300133810991130961799788765669648526
Total Liabilities123501226311744114241109786237637606652584549411639603892381232112697
Fixed Assets4627437142674523455427512418207220591940195319832014180013541104
CWIP773777622485343140306235133667395129267165129
Investments844120398094486262698950531012087136261699
Other Assets6106591258755472533951053924325427562422200317461723172916831455
Total Assets123501226311744114241109786237637606652584549411639603892381232112697
Delivery

Delivery Data: IPCALAB

#Date
1720
18%
2038
Value (Cr)Q/T
13
Del
48
Del
131
121-Oct1919
96
103938
219-Oct1814
31
75316
316-Oct1833
40
105120
415-Oct1913
32
76621
514-Oct1912
39
94317
613-Oct1919
65
116542
712-Oct1900
34
75819
89-Oct1915
18
65310
98-Oct1938
62
146641
107-Oct1938
26
66718
116-Oct1946
53
97941
125-Oct1951
41
65924
131-Oct1943
63
85736
1430-Sep1927
61
96137
1529-Sep1938
48
74924
1628-Sep1919
33
66421
1725-Sep1971
52
115529
1824-Sep1997
54
83720
1923-Sep1963
31
95216
2022-Sep1992
25
56416
2121-Sep2008
35
66121
2218-Sep2010
106
156972
2317-Sep1970
110
84651
2416-Sep1951
65
55033
2515-Sep1932
54
76434
2611-Sep1968
35
65017
2710-Sep1971
41
87029
289-Sep1964
25
66215
298-Sep1967
31
85317
307-Sep1959
18
5499
314-Sep1965
16
9579
323-Sep1956
58
125331
332-Sep1956
32
75016
341-Sep1988
43
95524
3531-Aug1975
70
176647
3628-Aug1950
54
115328
3727-Aug1960
24
85413
3826-Aug1952
89
134439
3925-Aug1928
83
144638
4024-Aug1920
53
145630
4121-Aug1911
37
114918
4220-Aug1900
45
135324
4319-Aug1904
143
114362
4418-Aug1882
152
182843
4517-Aug1885
1305
2119253
4614-Aug1734
68
144732
4713-Aug1796
337
181861
4812-Aug1767
26
114913
Daily Market Cap
DateTotal Market CapChangeChg %
21-Oct48,737c3,070c6.72
19-Oct45,667c1,154c2.47
17-Oct46,821c00
16-Oct46,821c1,586c3.28
15-Oct48,407c538c1.12
14-Oct47,869c335c0.69
13-Oct48,204c188c0.39
12-Oct48,016c515c1.06
09-Oct48,531c310c0.63
08-Oct48,841c490c0.99
06-Oct49,330c710c1.42
05-Oct50,041c639c1.29
01-Oct49,401c337c0.69
29-Sep49,064c155c0.31
28-Sep49,219c594c1.19
25-Sep49,812c949c1.87
24-Sep50,761c447c0.89
22-Sep50,315c284c0.56
17-Sep50,599c591c1.18
10-Sep50,008c28c0.06
07-Sep50,036c274c0.55
04-Sep49,762c00
Stock Checklist
Price is above from 52 week high low average: 85%
Stock is trading above all short term SMAs: NO
Stock is trading above all long term SMAs: YES
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: YES
Promoters are buying the stock: NO
Mutual Fund Holdings

Held by 250 fund scheme(s) across 30 fund house(s) as of Oct26 · Total value ₹30,116 Cr · 118 increasing / 38 decreasing · View in MF Pro →

Fund HouseSchemesWeight %ChangeValue (Cr)
HDFC Mutual Fund261.72%+0.10%9295.2
Kotak Mahindra Mutual Fund122.73%+0.13%6199.8
DSP Mutual Fund301.83%-0.01%4027.2
Nippon India Mutual Fund160.94%-2517.8
Axis Mutual Fund101.86%+0.06%1998
Edelweiss Mutual Fund181.53%+0.02%1183.5
HSBC Mutual Fund61.32%-1101
UTI Mutual Fund101.20%+0.29%858.5
Bandhan Mutual Fund120.79%+0.12%379.6
Franklin Templeton Mutual Fund21.57%-0.01%377
quant Mutual Fund42.34%+0.26%359.1
WhiteOak Capital Mutual Fund81.19%+0.39%337.1
Aditya Birla Sun Life Mutual Fund80.90%+0.01%277.4
Mirae Asset Mutual Fund63.32%-0.04%237.3
PGIM India Mutual Fund40.98%+0.16%209.8
Baroda BNP Paribas Mutual Fund82.68%-0.01%202.8
Union Mutual Fund101.70%+0.04%162.4
Tata Mutual Fund81.43%+0.04%161.6
Motilal Oswal Mutual Fund80.46%+0.01%65.8
Bank of India Mutual Fund20.68%-0.06%28.9
ICICI Prudential Mutual Fund80.76%+0.01%27.4
ITI Mutual Fund60.74%+0.01%27
Jio BlackRock Mutual Fund40.73%+0.55%26.6
Bajaj Finserv Mutual Fund22.40%-0.06%19.5
SBI Mutual Fund40.47%+0.02%18.4
Zerodha Mutual Fund40.33%-6.2
Navi Mutual Fund60.62%+0.02%5.2
LIC Mutual Fund22.33%-0.85%4.6
Groww Mutual Fund40.15%-1.1
Angel One Mutual Fund20.14%+0.01%0.2
Strategy Builder
Bulk Deals
Events
News
Exchange Filings
Annual Reports
Ratings & Research Reports
Concalls
Announcements
For research & education only — not investment advice. Not a SEBI-registered Investment Adviser or Research Analyst. Data may be delayed or inaccurate. Investments in securities markets are subject to market risks.
0